Italia markets closed

BMY Jan 2026 57.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,1200+0,0300 (+1,44%)
In data: 01:34PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente2,0900
Aperto2,1200
Denaro1,9400
Lettera2,4800
Prezzo d'esercizio57,50
Scadenza2026-01-16
Min-Max giorno2,1200 - 2,1200
Contratto - Min-MaxN/D
Volume1
Open Interest909
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri